Keyphrases
Treatment Response
100%
Anti-CTLA-4
100%
T Cell Infiltration
100%
Murine Tumor Model
100%
CT26
75%
P815
75%
Immune Checkpoint Inhibitors
50%
Treatment Efficacy
50%
Immune Checkpoint Inhibitor Therapy
50%
Tumor-infiltrating Leukocytes
50%
Cancer Treatment
25%
Treatment Outcome
25%
T Cells
25%
Macrophages
25%
Flow Cytometry
25%
Sampling Methods
25%
CD8+ T Cells
25%
Leukocyte Subsets
25%
Monocytes
25%
Tumor
25%
CD4+ T Cells
25%
Understanding Why
25%
Genetic Background
25%
Tumor Infiltration
25%
Fine-needle Aspiration
25%
Cancer Model
25%
Mouse Tumor Model
25%
Early Tumor
25%
Immune Infiltrates
25%
Non-uniform Response
25%
Animal-mouse
25%
Medicine and Dentistry
T Cell
100%
Neoplasm
100%
Immune Checkpoint Inhibitor
100%
Treatment Response
100%
Cancer Model
100%
Cellular Infiltration
100%
Leukocyte
50%
Cytotoxic T-Cell
25%
Macrophage
25%
Flow Cytometry
25%
Genetic Background
25%
Cancer Treatment
25%
T-Helper Cell
25%
Fine-Needle Aspiration
25%
Mouse Study
25%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Cancer Model
100%
Cell Infiltration
100%
Immune Checkpoints
100%
Tumor-Associated Macrophage
50%
Macrophage
25%
CD4
25%
Flow Cytometry
25%
Genetic Background
25%
CD8
25%
Preclinical Study
25%
Immunology and Microbiology
T Cell
100%
Cell Infiltration
100%
Tumor-Associated Macrophage
100%
Macrophage
50%
Cytotoxic T-Cell
50%
T-Helper Cell
50%
Preclinical Study
50%
Genetic Background
50%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Immune Checkpoint Inhibitor
100%
Cytotoxic T Lymphocyte Antigen 4
100%
Cancer Model
100%
Malignant Neoplasm
25%
Flow Cytometry
25%
Preclinical Study
25%
CD8 Antigen
25%